PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

625 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

⭐ Featured free samples

Three of our best full deep-analysis reports: hand-picked, free to read in full, no subscription required.

🔓 Free Sample
Nephrology ConfirmatoryGrade: Moderate

Finerenone Outperforms Spironolactone for Cardiorenal Protection in Moderate CKD

Finerenone emerges as the safer choice for CKD patients.

Read Free →
🔓 Free Sample
Neurology / Neuropharmacology ConfirmatoryGrade: Low

Tenecteplase Shortens Stroke Treatment and Transfer Times

Tenecteplase speeds up stroke thrombolysis compared to alteplase.

Read Free →
🔓 Free Sample
Rheumatology / Immunology ConfirmatoryGrade: Moderate

EULAR 2025 Streamlines Rheumatoid Arthritis DMARD Management to Nine Recommendations

New EULAR guidelines redefine RA management with DMARDs.

Read Free →
Showing 65 from 1 topic.Sort: Newest | Oldest
Curcumin Modestly Lowers HOMA-IR in Overweight Adults; Other Compounds Show Little Effect
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low

Curcumin may help combat insulin resistance in obesity.

Oral Orforglipron Weight Loss Across Six Trials: Efficacy, GI Tolerability, Gaps
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate

Oral orforglipron shows promise for significant weight reduction.

Retatrutide Versus Tirzepatide in T2DM: Indirect Network Meta-Analysis of Sparse Data
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low

Retatrutide outperforms in weight reduction for diabetes management.

Orforglipron Improves Physical Function More Reliably Than Psychosocial Measures in ATTAIN Trials
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate

Orforglipron boosts physical and psychosocial health in obesity.

Win Statistics Reanalysis Favors Early Metformin in Gestational Diabetes, Driven by Insulin Avoidance
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low

Early metformin shows promise for gestational diabetes control.

Intranasal Insulin and Postoperative Delirium in Diabetes: Exploratory Subgroup Signal
Analysis Perioperative / Anesthesia Hypothesis-generating Grade: Very Low
Also in Geriatrics, Endocrinology / Diabetes / Obesity

Can intranasal insulin protect against postoperative delirium in older patients?

CagriSema Adds About 7 Points of Weight Loss Over Semaglutide 2.4 mg
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate

CagriSema offers superior weight loss over semaglutide alone.

Narrative Review Maps Incretin Obesity Therapy: Efficacy Hierarchy, Safety, and Pipeline Agents
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low

GLP-1 and GIP agonists redefine obesity treatment possibilities.

Oral Obesity Drugs Across CKM Stages: Only Semaglutide Has Outcomes Data
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Also in Cardiology, Nephrology

Oral obesity drugs may redefine CKM syndrome treatment.

Pharmacist Obesity Care Shows Weight Benefits but Equity Evidence Remains Thin
Analysis Ambulatory Care / MTM Hypothesis-generating Grade: Low
Also in Endocrinology / Diabetes / Obesity

Do pharmacy interventions help reduce obesity and its inequities?

Semaglutide Plus Dapagliflozin: Short-Term Gains in Diabetic CKD
Analysis Nephrology Hypothesis-generating Grade: Very Low
Also in Endocrinology / Diabetes / Obesity

Could combining semaglutide and dapagliflozin benefit diabetic patients with kidney disease?

Prior GLP-1 Agonist Use Linked to Lower Post-Sepsis Mortality
Analysis Critical Care / ICU Hypothesis-generating Grade: Low
Also in Endocrinology / Diabetes / Obesity

GLP-1 agonists may enhance survival in sepsis for type 2 diabetes patients.

Once-weekly efsitora shows hospitalization outcomes similar to daily basal insulin
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low

Once-weekly insulin shows promising hospitalization outcomes in type 2 diabetes.

SGLT2 Inhibitors in Diabetic CKD: Metabolic Wins, Neutral Surrogates
Analysis Nephrology Confirmatory Grade: Moderate
Also in Endocrinology / Diabetes / Obesity

SGLT2 inhibitors offer metabolic benefits but risk volume depletion in diabetic CKD.

Hybrid Closed-Loop Therapy Raises Time in Range 10 Points in Preschoolers
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate
Also in Pediatrics

Hybrid closed-loop systems enhance pediatric diabetes control safely.